Sports Med Health Sci
The margin between therapeutic and toxic doses is extraordinarily wide, and the most common side effects are mild and manageable
This fall in liver fat is strongly associated with body weight loss, with close to maximal liver fat change occurring at approximately 20% total weight loss
Semaglutide added to basal insulin in type 2 diabetes (SUSTAIN 5): A randomized, controlled trial
G., Vernacotola, S., Mariotti, P., Bianchi, E., Calvani, M., De Gaetano, A., Chiurazzi, P., and Neri, G
While liraglutide and semaglutide have laid the foundation for GLP-1-based therapies, the introduction of tirzepatide (GLP-1/GIP) and retatrutide (GLP-1/GIP/GCGR) has demonstrated the potential for even greater weight loss and metabolic improvements